Literature DB >> 25424208

Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes.

Marta Valdivielso-Ramos1, Antonio Torrelo, Minia Campos, Marta Feito, Reyes Gamo, Jose Luis Rodriguez-Peralto.   

Abstract

Little is known about the incidence and management of dermatofibrosarcoma protuberans (DFSP) in children. We conducted a retrospective review of all patients younger than 18 years of age treated for DFSP over a period of 11 years (2000-2011) in Madrid, Spain. The sample consisted of 13 children. The average annual incidence of DFSP in the pediatric population corresponded to 1.02 cases per million person-years (95% confidence interval 0.55, 1.73). Sites of involvement were diverse, with 15.3% of tumors found in acral locations. The median tumor size was 3.5 cm × 3 cm and the median time from apparent onset to diagnosis was 36 months. Histopathologic examination revealed conventional (77.0%), pigmented (15.4%), and myxoid (7.6%) variants. The mitotic index was consistently <5 per 10 high-power fields. All lesions were removed using surgical excision. One patient developed a local recurrence because of initial affected margins; none developed metastases. The median duration of clinical follow-up was 70.5 months. This study estimated the average annual incidence rate of DFSP in a population of patients younger than 18 years and reviewed the experience of several hospitals in the management of this tumor.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25424208     DOI: 10.1111/pde.12371

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  9 in total

1.  The spectrum of skin biopsies and excisions in a pediatric skin center.

Authors:  Martin Theiler; Kathrin Neuhaus; Katrin Kerl; Lisa Weibel
Journal:  Eur J Pediatr       Date:  2017-09-25       Impact factor: 3.183

Review 2.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08

3.  Photoletter to the editor: Pigmented dermatofibrosarcoma protuberans in a 4-year-old girl and ultrasonographic findings.

Authors:  Ryo Tanaka; Kiichi Inagawa; Naoki Kanomata; Jiro Hata; Wataru Fujimoto
Journal:  J Dermatol Case Rep       Date:  2015-06-30

4.  Clinical Outcome of Dermatofibrosarcoma Protuberance. Report From the Bone and Soft Tissue Tumor (BSTT) Registry in Japan.

Authors:  Tomoki Nakamura; Akira Kawai; Kunihiro Asanuma; Tomohito Hagi; Akihiro Sudo
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.406

5.  A case of congenital dermatofibrosarcoma protuberans in a 2-year-old child.

Authors:  Francesca Caroppo; Roberto Salmaso; Elena Fontana; Anna Belloni Fortina
Journal:  JAAD Case Rep       Date:  2020-05-19

6.  Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.

Authors:  Marjorie Parker David; Ashley Funderburg; James P Selig; Rebecca Brown; Pip M Caliskan; Lee Cove; Gayle Dicker; Lori Hoffman; Tammi Horne; Jerad M Gardner
Journal:  JAMA Netw Open       Date:  2019-08-02

7.  Clinicopathological features of fibrosarcomatous dermatofibrosarcoma protuberans and the construction of a back-propagation neural network recognition model.

Authors:  Yanan Li; Jiaqi Liang; Xuewen Xu; Xian Jiang; Chuan Wang; Siyuan Chen; Bo Xiang; Yi Ji
Journal:  Orphanet J Rare Dis       Date:  2021-01-26       Impact factor: 4.123

8.  Risk factors related to postoperative recurrence of dermatofibrosarcoma protuberans: A retrospective study and literature review.

Authors:  Jian-Xia Xiong; Tao Cai; Li Hu; Xiao-Li Chen; Kun Huang; Ai-Jun Chen; Ping Wang
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

9.  Dermatofibrosarcoma protuberans in pediatric patients: A diagnostic and management challenge.

Authors:  Anna H Buteau; Brett H Keeling; Lucia Z Diaz; Margarita Larralade; Paula Luna; Chandra Krishnan; Moise L Levy
Journal:  JAAD Case Rep       Date:  2018-01-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.